baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

JP Morgan Put 260 AMGN 17.05.2024/ DE000JK2PHS7 /

2024-05-10 3:40:24 PM	Chg.-0.005	Bid10:00:38 PM	Ask10:00:38 PM	Underlying	Strike price	Expiration date	Option type
0.004EUR	-55.56%	- Bid Size: -	- Ask Size: -	Amgen Inc	260.00 USD	2024-05-17	Put

GlobeNewswire 05-09 Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan

GlobeNewswire 05-09 argenx Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 05-08 CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 ...

GlobeNewswire 05-08 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

TeleTrader 05-08 US closes flat to higher with more earnings on the horizon

GlobeNewswire 05-08 Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination ...

GlobeNewswire 05-07 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...

TeleTrader 05-03 US closes higher after softer-than-expected jobs print

TeleTrader 05-03 Wall Street surges on open as jobs report sparks rate cut hopes

TeleTrader 05-03 Amgen soars 14% on positive weight-loss drug data

TeleTrader 05-02 Amgen Q1 revenue jumps 22% to $7.4 billion

TeleTrader 05-02 US surges at close as traders weigh Fed remarks

TeleTrader 05-02 US opens higher, Dow jumps 240 points

GlobeNewswire 05-02 Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Canc...

TeleTrader 05-02 US higher premarket after Fed's decision

GlobeNewswire 05-01 Fight Colorectal Cancer Launches ChatCRC: An AI-Powered Chatbot Revolutionizing Colorectal Cancer Su...

GlobeNewswire 05-01 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...

GlobeNewswire 04-30 Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab bios...

GlobeNewswire 04-24 Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeti...

TeleTrader 04-24 Wall Street opens mostly higher amid earnings jitters

GlobeNewswire 04-23 Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...

GlobeNewswire 04-16 Turnstone Biologics Appoints William Waddill to its Board of Directors

GlobeNewswire 04-15 IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness

GlobeNewswire 04-15 Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer

GlobeNewswire 04-15 Shah Capital nominates two highly qualified independent director candidates for Novavax

JP Morgan Put 260 AMGN 17.05.2024/ DE000JK2PHS7 /

If you wish to receive reply to your feedback, please provide your email address.